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Abstract
Gastro-oesophageal reflux (GOR) is one of the most common causes of chronic cough in Western
countries, responsible for 10 to 40% of cases. In Japan, however, GOR-associated chronic cough
(GOR-CC) has been rarely reported and its clinical manifestation including frequency of
concomitant reflux laryngitis is poorly known.
We have analyzed prevalence and clinical characteristics of patients who were diagnosed as having
GOR-CC among adult patients with chronic cough (≥ 8 weeks) who visited our asthma and cough
clinic over a period of 19 months. Diagnosis of GOR-CC was based on the response of coughing
to a proton-pump inhibitor (lansoprazole™) and/or positive results of 24 h ambulatory esophageal
pH monitoring. Laryngeal involvement was based on symptoms or objective diagnosis by specialists.
GOR-associated chronic cough was diagnosed in 7.1% (8 of 112) of chronic cough patients. In
addition to the demographic data which were consistent with the characteristics of patients with
GOR-CC in the Western populations, including gender (6 females), age (mean ± SE, 56.9 ± 5.8
years), duration of cough (9.9 ± 3.3 months), lack of gastrointestinal symptoms (3 of 8) and
complication with other causes of cough (5 of 8), we found the standard range of body mass index
(23.9 ± 1.5 kg/m2) and high incidence of concomitant reflux laryngitis (5 of 8) in the present 8
patients. Among 4 patients who could stop treatment with temporal resolution of cough, cough
recurred in 3 patients, 1 week to 8 months after the discontinuation.
In conclusion, GOR-CC is a less frequent cause of chronic cough in Japan than in Western
countries. Signs or symptoms of laryngitis may be important as clues to suspicion of GOR-CC.
Findings
Despite the established evidence that gastro-oesophageal
reflux (GOR) causes 10 to 40% of chronic cough [1], and
the prevalence of GOR-associated chronic cough (GOR-
CC) is increasing in the Western populations [2], this con-
dition has been rarely reported in Japan and its clinical
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manifestation is not well characterized. Only one case
among 37 patients with chronic dry cough was diagnosed
as having GOR-CC in our previous study carried out in the
mid '90s [3]. Our present study is concerned with the ris-
ing number of cases of GOR-CC in Japan and of concom-
itant reflux laryngitis which is another major extra-
oesophageal manifestation of GOR.
We studied 112 consecutive adult patients with chronic
cough (≥ 8 weeks) who newly visited the asthma and
cough clinic of Kyoto University Hospital from June 2002
to December 2003. Diagnostic investigations included
questionnaire, physical examination, blood tests, chest
and sinus radiographs, pulmonary function, airway
responsiveness and cough sensitivity tests, and sputum
induction. Diagnosis of GOR-CC was on the basis of
response to 8 week-course of a proton-pump inhibitor
(PPI, lansoprazole™) and/or positive results of 24 h
ambulatory esophageal pH monitoring (pH Digitrapper
MarkII Gold 6,200, Synetics Medical Comp., Sweden) [4].
Laryngeal involvement was based on symptoms or objec-
tive diagnosis by specialists; laryngeal irritation, globus
sensation, or signs of laryngeal inflammation. Diagnosis
of cough variant asthma (CVA) was based on the follow-
ing criteria; an isolated chronic cough without dyspnea or
wheezing not audible on auscultation, airway hyperre-
sponsive to methacholine and symptomatic improve-
ment of coughing with the use of inhaled beta-2 agonists,
sustained release theophylline or both, no past history of
asthma, or upper respiratory tract infection within the
past 8 weeks [5]. When patients did not undergo metha-
choline test due to failure of informed consent or pre-
sented normo-responsive result but responded to
bronchodilator therapy, they were diagnosed as having
probable CVA[6]. Diagnosis of sinobronchial syndrome
was made on a positive result of sinus images and
improvement of cough as well as the symptom related to
chronic sinusitis with antibiotics [7,8]. Diagnosis of
atopic cough was made according to the criteria proposed
by Japanese Cough Research Society [6,9]. If examinations
and intensive therapeutic trials for GOR-CC, CVA, sino-
bronchial syndrome, and atopic cough including inhaled
corticosteroids and anti-reflux treatment were failed, the
chronic cough was considered unexplained (idiopathic).
All the chronic cough patients showed normal chest radi-
ographs.
Causes of chronic cough of the 112 patients were as fol-
lows; 38 CVA, 24 probable CVA (12 patients did not
undergo airway responsiveness test and 12 presented
normo-responsive results but responded to bronchodila-
tor therapy), 17 atopic cough, 9 sinobronchial syndrome,
8 GOR-CC, 7 postinfectious chronic cough, 2 other mis-
cellaneous conditions, 4 unexplained cough. Twelve
patients were lost before diagnosis was made. Nine
patients had multiple conditions. There were 15 ex-smok-
ers, and 2 current smokers. No patients had ACE inhibitor
associated chronic cough. The 8 patients (7.1%) with
GOR-CC were diagnosed on the basis of response to the
PPI (n = 7) and/or positive results of 24 h ambulatory
esophageal pH monitoring (n = 4). One patient who com-
plained of chronic cough and heartburn but did not
respond to the PPI showed esophageal pH more than 7 in
66.9% of the 24 h monitoring period, and was diagnosed
as having GOR-CC due to alkaline regurgitation.
Demographics of the 8 patients were presented in Table 1.
Mean body mass index (BMI) was classified as normal at
23.9 (range, 19.4–28.0) kg/m2, which was not signifi-
cantly different from that of the general population in the
present study (23.3 kg/m2, 16.5–36.3 kg/m2). Frequent
association of reflux laryngitis (5 of 8) was observed. Two
patients complained of temporal association of coughing
and heartburn. Five patients were complicated with other
causes of chronic cough; 3 with CVA/probable CVA on
inhaled corticosteroids or an anti-leukotriene receptor
antagonist, 1 with sinobronchial syndrome on low dose
of macrolide, 1 with atopic cough on an anti-histamine
receptor antagonist. Airway responsiveness was tested in 4
patients among whom 2 with complication of CVA
showed hyperresponsiveness. Cough sensitivity was
examined in 2 patients; one complicated with atopic
cough had hypersensitivity, another with CVA did not. All
were non-smokers and produced minimal amount of spu-
tum or none.
In 7 patients, their coughing with or without laryngeal
symptoms was alleviated and ceased within a few days
after initiation of PPI. However, in 3 of 4 patients who had
Table 1: Patients' characteristics
Age (years) 56.9 ± 5.8
Gender (male/female) 2/6
Cough duration (months) 9.9 ± 3.3
Body mass index (kg/m2) 23.9 ± 1.5
FEV1 (%predicted) 98.5 ± 5.3
Intraesophageal symptoms* (yes/no) 5/3
Reflux laryngitis (yes/no) 5/3
Values are expressed as mean ± SE. * heart burn and acid reflux.Cough 2007, 3:1 http://www.coughjournal.com/content/3/1/1
Page 3 of 4
(page number not for citation purposes)
stopped treatment with resolution of cough, coughing
recurred 1 week to 8 months later. Coughing, laryngitis
and heart burn observed in one patient with alkaline
regurgitation subsided without any treatment.
In the present study, GOR-CC was a less frequent cause of
chronic cough than in the studies of the Western popula-
tions [1,2], although there was a small increase when
comparing with our previous study [3]. The low preva-
lence of GOR-CC in the present study might be biased by
the studied population in a university hospital, but may
reflect low prevalence of GOR in the general population
in Japan where 21 to 27% of the general population are
overweight (BMI  25 kg/m2) [10] and endoscopically
diagnosed and/or symptomatic GOR is reported to be
16% and 18% in population based studies [11,12]. This is
in contrast with the finding in Western countries where 34
to 78% of the general population are overweight [10] and
21 to 59% of the general population have symptomatic
GOR [13].
In one patient who complained of cough and heartburn,
and presented laryngitis and frequent alkaline regurgita-
tion, the cough had ceased spontaneously as well as heart-
burn and laryngitis. Although there are no diagnostic
criteria for alkaline regurgitation, the patient's cough was
clinically considered caused by GOR-CC due to alkaline
regurgitation.
The present study has shown frequent association of
reflux laryngitis and GOR-CC. To date, frequency of this
association has not been clarified [2]. In a study of extra-
oesophageal manifestations in GOR, laryngeal manifesta-
tions are observed in 10.4% of patients with GOR and are
significantly related to higher age, longer GOR duration
and obesity [14], although these features were not the
cases for the 5 patients with average age of 47.4 (28–59)
years and BMI of 22.4 (19.2–28) kg/m2 in the present
study. Except the frequent incidence of concomitant reflux
laryngitis and standard range of BMI, characteristics of the
present patients including complication with other causes
of chronic cough were consistent with those in the previ-
ous studies of GOR-CC in the Western populations
[1,4,15,16]. Since chronic cough per se can be a trigger of
GOR possibly through increased transdiaphragmatic pres-
sure and transient lower oesophageal sphincter relaxation
[17], GOR-CC should be considered when cough remains
despite the institution of specific treatment to other causes
of cough.
We conclude that GOR-CC is a less frequent cause of
chronic cough in Japan than in Western countries. The
presence of reflux laryngitis may be an important clue to
suspicion of GOR-CC.
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